Exploring the potential of short-acting immune checkpoint blockers in the therapy of sepsis

Forschungsstelle

INNOSUISSE

Projektnummer

118.041 IP-LS

Projekttitel

Exploring the potential of short-acting immune checkpoint blockers in the therapy of sepsis

Projekttitel Englisch

Exploring the potential of short-acting immune checkpoint blockers in the therapy of sepsis

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Schlüsselwörter	-	-	-
Abstract	-	-	-

Kategorie	Text
Schlüsselwörter (Englisch)	Life sciences, Human medicine
Abstract (Englisch)	Sepsis is a life-threatening disease lacking effective treatment options. Based on our scientific discovery, we have developed an innovative therapy that targets the dysfunctional host response. This project aims to validate our lead compound and establish its efficacy in preclinical sepsis models.